Latest News

View All Recent News »

Alimera Sciences Limited Signs Exclusive ILUVIEN® Distributor for Italy, San Marino and Vatican City

August 13, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Alimera Sciences Limited, its European subsidiary...

Read More »

Alimera Sciences Reports Second Quarter 2015 Financial Results

August 10, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the second quarter ended June 30,...

Read More »

Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results

July 30, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter fiscal year 2015...

Read More »